Velarion Records
Free. Unsubscribe any time.

LIGAND PHARMACEUTICALS INC (LGND)

LIGAND PHARMACEUTICALS INC filed 20 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 111 transactions and 90,292 shares. None carries the SEC's AFF10B5ONE flag; all 20 name a plan in a footnote. 7 results prints are on file in the same window.

What stands out

Trades in LIGAND PHARMACEUTICALS INC 111

Adoption dates in LIGAND PHARMACEUTICALS INC 0

Results prints in LIGAND PHARMACEUTICALS INC 7

Trades before a print in LIGAND PHARMACEUTICALS INC 14

Interval to LIGAND PHARMACEUTICALS INC’s next reported results date

How the interval and sources are counted →

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.